Pablo M Lavados1, Lorena Hoffmeister2, Ana M Moraga3, Angelica Vejar4, Carolina Vidal2, Constanza Gajardo4, Bernardita Portales5, Daniela San Martín4, Eduardo Lopez4, Alexis Rojo4, Veronica V Olavarria6, Juan Almeida7, Alejandro M Brunser6, Paula Muñoz Venturelli8, Violeta Diaz6, Arnold Hoppe6, Claudio Sacks9. 1. Department of Neurology and Psychiatry, Clínica Alemana de Santiago, Universidad del Desarrollo, Clínica Alemana, School of Medicine, Santiago, Chile. Electronic address: plavados@alemana.cl. 2. School of Public Health, Universidad Mayor, Santiago, Chile. 3. School of Public Health and School of Medicine, Universidad de Concepción, Concepción, Chile. 4. Herminda Martin Clinical Hospital of Chillán, Ñuble Health Service, Chillan, Chile. 5. Clinical Studies Centre and Bioethics Centre, Institute of Science and Medical Innovation, Universidad del Desarrollo, Clínica Alemana, School of Medicine, Santiago, Chile. 6. Department of Neurology and Psychiatry, Clínica Alemana de Santiago, Universidad del Desarrollo, Clínica Alemana, School of Medicine, Santiago, Chile. 7. Department of Neurology and Psychiatry, Clínica Alemana de Santiago, Universidad del Desarrollo, Clínica Alemana, School of Medicine, Santiago, Chile; Neurology Service, Hospital Padre Hurtado, Santiago, Chile. 8. Department of Neurology and Psychiatry, Clínica Alemana de Santiago, Universidad del Desarrollo, Clínica Alemana, School of Medicine, Santiago, Chile; Clinical Studies Centre and Bioethics Centre, Institute of Science and Medical Innovation, Universidad del Desarrollo, Clínica Alemana, School of Medicine, Santiago, Chile; The George Institute for Global Health, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia. 9. Department of Neurology, School of Medicine, Universidad de Valparaíso, Valparaíso, Chile.
Abstract
BACKGROUND: Stroke is a leading cause of disability and death worldwide. The best estimates of local, national, and global burden of stroke are derived from prospective population-based studies. We aimed to investigate the incidence, risk factors, long-term prognosis, care, and quality of life after stroke in the Ñuble region of Chile. METHODS: We did a prospective community-based study with use of multiple overlapping sources of hospitalised, ambulatory, and deceased cases. Standardised diagnostic criteria were used to identify and follow up all cases occurring in the resident population of the Ñuble region, Chile (in a low-income rural-urban population including predominantly people of Indigenous-European heritage), for 1 year. Participants were included if they had a clinical diagnosis of stroke confirmed according to the study criteria. All cases were adjudicated by vascular neurologists. Incidence rates of first-ever stroke were calculated from the population of Ñuble according to the 2017 national census. FINDINGS: From April 1, 2015, to March 31, 2016, we ascertained 1103 stroke cases, of which 890 (80·7%) were first-ever incident cases. The mean age of patients with first-ever stroke was 70·3 years (SD 14·1) and 443 (49·8%) were women. A CT scan was obtained in 801 (90%) of 890 patients (mean time from symptom onset to scan of 13·4 h (SD 29·8). The incidence of first-ever stroke age-adjusted to the world population was 121·7 (95% CI 113·7-130·1) per 100 000. The age-adjusted incidence rates, per 100 000 inhabitants, by main pathological subtypes were as follows: ischaemic stroke (101·5 [95% CI 90·9-113·0]); intracerebral haemorrhage (17·9 [13·5-23·4]), and subarachnoid haemorrhage (4·2 [2·1-7·3]). The 30-day case-fatality rate was 24·6% (21·9-27·6). At 6 months after the stroke, 55·9% (432 of 773) of cases had died or were disabled, which increased to 61·0% (456 of 747) at 12 months. Health-related quality of life in survivors was low at 6 months, improving slightly at 12 months after the stroke. INTERPRETATION: The incidence of stroke in this low-resource population was higher than our previous finding in northern Chile and within the mid-range of most population-based stroke studies. This result was due mainly to a higher incidence of ischaemic stroke, probably associated with increasing age and a high prevalence of cardiometabolic risk factors in the population studied. Our findings suggest that more should be done for the prevention and care of stroke in communities like the Ñuble population. FUNDING: The National Agency for Research and Development and the Technology-Health Research Fund, Clínica Alemana de Santiago, Boehringer Ingelheim, Bristol Meyers Squibb, The Herminda Martin Clinical Hospital of Chillán, Universidad Mayor, and Universidad de Concepción.
BACKGROUND:Stroke is a leading cause of disability and death worldwide. The best estimates of local, national, and global burden of stroke are derived from prospective population-based studies. We aimed to investigate the incidence, risk factors, long-term prognosis, care, and quality of life after stroke in the Ñuble region of Chile. METHODS: We did a prospective community-based study with use of multiple overlapping sources of hospitalised, ambulatory, and deceased cases. Standardised diagnostic criteria were used to identify and follow up all cases occurring in the resident population of the Ñuble region, Chile (in a low-income rural-urban population including predominantly people of Indigenous-European heritage), for 1 year. Participants were included if they had a clinical diagnosis of stroke confirmed according to the study criteria. All cases were adjudicated by vascular neurologists. Incidence rates of first-ever stroke were calculated from the population of Ñuble according to the 2017 national census. FINDINGS: From April 1, 2015, to March 31, 2016, we ascertained 1103 stroke cases, of which 890 (80·7%) were first-ever incident cases. The mean age of patients with first-ever stroke was 70·3 years (SD 14·1) and 443 (49·8%) were women. A CT scan was obtained in 801 (90%) of 890 patients (mean time from symptom onset to scan of 13·4 h (SD 29·8). The incidence of first-ever stroke age-adjusted to the world population was 121·7 (95% CI 113·7-130·1) per 100 000. The age-adjusted incidence rates, per 100 000 inhabitants, by main pathological subtypes were as follows: ischaemic stroke (101·5 [95% CI 90·9-113·0]); intracerebral haemorrhage (17·9 [13·5-23·4]), and subarachnoid haemorrhage (4·2 [2·1-7·3]). The 30-day case-fatality rate was 24·6% (21·9-27·6). At 6 months after the stroke, 55·9% (432 of 773) of cases had died or were disabled, which increased to 61·0% (456 of 747) at 12 months. Health-related quality of life in survivors was low at 6 months, improving slightly at 12 months after the stroke. INTERPRETATION: The incidence of stroke in this low-resource population was higher than our previous finding in northern Chile and within the mid-range of most population-based stroke studies. This result was due mainly to a higher incidence of ischaemic stroke, probably associated with increasing age and a high prevalence of cardiometabolic risk factors in the population studied. Our findings suggest that more should be done for the prevention and care of stroke in communities like the Ñuble population. FUNDING: The National Agency for Research and Development and the Technology-Health Research Fund, Clínica Alemana de Santiago, Boehringer Ingelheim, Bristol Meyers Squibb, The Herminda Martin Clinical Hospital of Chillán, Universidad Mayor, and Universidad de Concepción.
Authors: Gregory Y H Lip; Deirdre A Lane; Radosław Lenarczyk; Giuseppe Boriani; Wolfram Doehner; Laura A Benjamin; Marc Fisher; Deborah Lowe; Ralph L Sacco; Renate Schnabel; Caroline Watkins; George Ntaios; Tatjana Potpara Journal: Eur Heart J Date: 2022-07-07 Impact factor: 35.855
Authors: Mohammad H Rahbar; Martin Medrano; Franck Diaz-Garelli; Cosme Gonzalez Villaman; Sepideh Saroukhani; Sori Kim; Amirali Tahanan; Yahaira Franco; Gelanys Castro-Tejada; Sarah A Diaz; Manouchehr Hessabi; Sean I Savitz Journal: Ann Clin Transl Neurol Date: 2022-02-09 Impact factor: 4.511
Authors: Kalliopi Tsakpounidou; Jan van der Merwe; Marianne Elisabeth Klinke; Chris Webb; Sheila Cristina Ouriques Martins; Hariklia Proios Journal: Front Public Health Date: 2022-04-18
Authors: Jutta M Adelin Jørgensen; Dirk Lund Christensen; Karoline Kragelund Nielsen; Halima Saleh Sadiq; Muhammad Yusuf Khan; Ahmed M Jusabani; Richard Walker Journal: Front Neurol Date: 2022-07-28 Impact factor: 4.086